Printable version AVAC released the first issue of Px Wire for 2011, which takes inventory of the regulatory, trial-planning and scientific agenda-setting steps that are being taken with respect to recent positive trial results. It reviews ongoing and proposed next steps that have been triggered by the Thai prime-boost AIDS vaccine trial, the CAPRISA 004 microbicide trial and the iPrEx trial of once-daily TDF/FTC for pre-exposure prophylaxis. The report can be found here.
 |
|
 |
|||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||